Skip to content

Armstrong, Fleming & Moore, Inc: SCZ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Armstrong, Fleming & Moore, Inc on SCZ, newest first. How the timeline and the estimate are built.

Armstrong, Fleming & Moore, Inc held 4,616 SCZ shares at 2026-06-30 per its 13F-HR filed 2026-07-28.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 4,616 shares
    Change vs previous 13F -146 shares

    0.13% of the 13F portfolio, value $379,749.

    13F-HR 0001990099-26-000004 filed by Armstrong, Fleming & Moore, Inc
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 4,762 shares
    Change vs previous 13F +951 shares

    0.16% of the 13F portfolio, value $373,415.

    13F-HR 0001990099-26-000002 filed by Armstrong, Fleming & Moore, Inc
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 3,811 shares
    Change vs previous 13F +51 shares

    0.14% of the 13F portfolio, value $295,493.

    13F-HR 0001990099-26-000001 filed by Armstrong, Fleming & Moore, Inc
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,760 shares
    Change vs previous 13F 0 shares

    0.14% of the 13F portfolio, value $288,465.

    13F-HR 0001990099-25-000003 filed by Armstrong, Fleming & Moore, Inc
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 3,760 shares
    Change vs previous 13F not available

    0.15% of the 13F portfolio, value $273,275.

    13F-HR 0001085146-25-004076 filed by Armstrong, Fleming & Moore, Inc
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).